Michael Allen Jerman serves as Executive at Inhibitor Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Michael Allen Jerman has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 21, 2025 involved receiving (via award) 4,183 shares valued at $13.2K.
Michael Allen Jerman currently holds 4,183 shares of Inhibitor Therapeutics, Inc. (INTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Allen Jerman has been a net neutral trader of INTI stock. They have purchased $0 and sold $0 worth of shares.
Michael Allen Jerman's most recent insider trade was on Nov 21, 2025, when they sold 4,183 shares at $3.16 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |